Precipio Diagnostics

Precipio Diagnostics

Precipio Diagnostics is a New Haven, Connecticut-based company developing a platform delivering diagnostic technology.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

October 28, 2013
Precipio Diagnostics raises a $1,800,000 series B round from Connecticut Innovations, Enhanced Capital Partners, Ironwood Capital and Kuzari.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Precipio Diagnostics Series B round
1,800,000
October 28, 2013
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 9, 2020
BioSpace
- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted Precipio's HemeScreen technology to launch molecular testing assay for hematologic malignancies such as myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). As part of Precipio's recently launched Reagent Rental program, CHCWM's laboratory is in the process of validati
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.